Compare ENTA & PSFE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ENTA | PSFE |
|---|---|---|
| Founded | 1995 | 1996 |
| Country | United States | United Kingdom |
| Employees | N/A | 2900 |
| Industry | Biotechnology: Pharmaceutical Preparations | Business Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 486.3M | 390.7M |
| IPO Year | 2012 | N/A |
| Metric | ENTA | PSFE |
|---|---|---|
| Price | $12.70 | $6.92 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 5 | 5 |
| Target Price | ★ $20.40 | $10.15 |
| AVG Volume (30 Days) | 155.3K | ★ 462.1K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 29.93 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $102,814,000.00 | N/A |
| Revenue This Year | $5.91 | $8.50 |
| Revenue Next Year | N/A | $5.85 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 16.48 | N/A |
| 52 Week Low | $4.09 | $5.95 |
| 52 Week High | $17.15 | $18.15 |
| Indicator | ENTA | PSFE |
|---|---|---|
| Relative Strength Index (RSI) | 41.06 | 47.58 |
| Support Level | $12.09 | $6.58 |
| Resistance Level | $15.52 | $7.62 |
| Average True Range (ATR) | 0.81 | 0.43 |
| MACD | -0.15 | 0.06 |
| Stochastic Oscillator | 4.86 | 48.15 |
Enanta Pharmaceuticals Inc is a biotechnology company that uses a chemistry-based drug discovery approach to develop small-molecule candidates for virology and immunology applications. It focuses on Virology and Immunology. Its active development programs in virology are focused on respiratory syncytial virus, or RSV, and SARS-CoV-2, and Hepatitis B virus. In immunology, the company is engaged in designing and developing potent and selective, oral small molecule inhibitors for the treatment of type 2 inflammatory disease. The company has collaborated with AbbVie, which markets its protease inhibitor paritaprevir, with additional inhibitors in development. The company generates the majority revenue in the form of royalty revenue.
Paysafe Ltd is an integrated payments platform. Its core purpose is to enable businesses and consumers to connect and transact seamlessly through capabilities in payment processing, digital wallet, and online cash solutions. The company provides payment solutions through three primary lines of business: Integrated Processing, Digital Wallet and eCash Solutions. It derives a majority of revenue from the USA followed by Germany, the UK, and all other countries.